tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Lebowitz, 190 are a BUY (59.38%), 93 are a HOLD (29.06%), 37 are a SELL (11.56%).
Analyst David Lebowitz, currently employed at BMO, carries an average stock price target met ratio of 70.02% that have a potential upside of 39.79% achieved within 245 days. Previously, David Lebowitz worked at CITI.
David Lebowitz’s has documented 606 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Energy sectors.
Most recent stock forecast was given on IONS, Ionis Pharmaceuticals.
Analyst best performing recommendations are on PLRX (PLIANT THERAPEUTICS ).
The best stock recommendation documented was for PLRX (PLIANT THERAPEUTICS ) at 3/4/2025. The price target of $1.5 was fulfilled within 1 day with a profit of $0.15 (11.11%) receiving and performance score of 111.11.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Buy Since 26-Sep-2023
$4.5
$3.47 (336.89%)
$7.5
Buy Since 03-Jun-2025
$6
$4.97 (482.52%)
$6
2 months 9 days ago
(30-Jun-2026)
0/5 (0%)
$4.79 (395.87%)
Buy Since 29-Nov-2023
$4
$2.86 (250.88%)
$4
5 months 3 days ago
(07-Apr-2026)
3/7 (42.86%)
$2.62 (189.86%)
578
Buy Since 30-Mar-2022
$4
$2.86 (250.88%)
$2
7 months 4 days ago
(06-Feb-2026)
1/2 (50%)
$2.61 (187.77%)
722
Buy Since 01-Apr-2025
$6
$4.86 (426.32%)
1 years 5 months 9 days ago
(01-Apr-2025)
0/1 (0%)
$4.09 (214.14%)
Which stock is David Lebowitz most bullish on?
Which stock is David Lebowitz most reserved on?
What Year was the first public recommendation made by David Lebowitz?
